Exelixis reported $51.62M in EBIT for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -15301000 28.41M
Acceleron Pharma XLRN:US $ -70630000 6.97M
Agios Pharmaceuticals AGIO:US $ -91152000 70K
Akebia Therapeutics AKBA:US $ -54886000 24.46M
Amgen AMGN:US $ 2378M 45M
AstraZeneca AZN:LN -4000000 1.45B
Bayer BAYN:GR 1.22B 426M
Biomarin Pharmaceutical BMRN:US $ -35997000 47.67M
Bluebird Bio BLUE:US $ -196779000 44.06M
Bristol Myers Squibb BMY:US $ 2985M 18M
Cytokinetics CYTK:US $ -69201000 14.4M
Dicerna Pharmaceuticals DRNA:US $ -20272000 19.97M
Eisai 4523:JP 5.5B 49.91B
Eli Lilly And LLY:US $ 2055.2M 626.8M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Exelixis EXEL:US $ 51.62M 71.39M
Genmab GEN:DC 890M 103M
Glaxosmithkline GSK:US 2.67B 712M
Immunogen IMGN:US $ -34234000 6.86M
IONIS PHARMACEUT IONS:US $ -85849000 12.88M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 5352M 3083M
Mirati Therapeutics MRTX:US $ -79499000 84.69M
Moderna Inc MRNA:US 3.56B 496M
Nektar Therapeutics NKTR:US $ -113596000 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 23.3M
Novartis NOVN:VX 3.48B 77M
Pfizer PFE:US $ 9254M 2592M
Puma Biotechnology PBYI:US $ -8954000 7.68M
Seattle Genetics SGEN:US $ -297963000 208.36M
Takeda 4502:JP 97.43B 151.12B
Ultragenyx Pharmaceutical RARE:US $ -89828000 7.05M
Xencor XNCR:US $ -41300000 50.39M
YTE INCY:US $ 247.47M 92.16M